Cover Image

PAPERBACK
$43.50



View/Hide Left Panel

Time to Licensure (years)

Time to Adoption (years)

Efficacy

Number of doses

Cost per dose (dollars)

3

2–5

(dependent on price)

0.99

3–5

10

3

2–5

(dependent on price)

0.95

3–5

10

3

2

0.95

1

1

5

2

0.80

(against severe disease in young children)

2+booster

15

5

2

0.80

(against severe disease in young children)

1–2

15

2

2

0.80

(against severe disease in young children)

1

10

5

2

0.90

(against severe disease in young children)

1

10

5

2

0.90

(against severe disease in young children)

1

10

1

2

(endemic areas)

0.80

2–3

2

5–8

 

0.80–0.90

2–3

2

approx. 10

2

0.80–0.90

(for a multivalent vaccine)

1–2

2

6–8

2–5

0.80

(depends on adjuvant or carrier development)

2

5

5

2

0.80

1–2

20

5–7

2

0.90

1–2

2

3–5

2

0.65

2–3

2

2–4

2

(endemic areas)

0.90

1

5



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement